Pressure grows to create drugs for 'Superbugs'
Government officials, drug companies and medical experts, faced with outbreaks of antibiotic-resistant "superbugs," are pushing to speed up the approval of new antibiotics, a move that is raising safety concerns among some critics. The need for new antibiotics is so urgent, supporters of an overhaul say, that lengthy studies involving hundreds or thousands of patients should be waived in favor of directly testing such drugs in very sick patients. Influential lawmakers have said they are prepared to support legislation that allows for faster testing.
- 2015 OPPS Proposed Rule Detailed
- Critical Times for Small and Rural Hospitals
- 4 Hot Healthcare Exec Titles; 1 Not
- Physician Pay Increasingly Linked to Value-based Metrics
- MU Slides into Summer of Discontent
- Providence, Swedish Health Launch Employer-Driven ACO
- Fees Lurk in Health Plans' Shift to e-Payments
- Doc Shortage 'Fix' Is a Disaster Waiting to Happen
- Advanced EHRs Save 10% Per Patient, Study Says
- Infuriated by MOC Rules, Physicians Unleash on Certification Boards